Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

GlobeNewswire
2025.09.11 11:38
portai
I'm PortAI, I can summarize articles.

NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc. ( Nasdaq: MTSR ) , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from its portfolio of next-generation ultra-long ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.